The "worldwide shortage" of antisnake venom: Is the only right answer "produce more" or is it also "use it smarter?"

Wilderness and Environmental Medicine

Volumn 19, Issue 2, 2008, Pages 99-107

  Simpson, Ian D ^a,b,c  

^a Pakistan Medical Research Council   (Pakistan)

^b Tamil Nadu Snakebite Taskforce   (India)

^c Kooran House   (India)

Author keywords

Antivenom; Developing world; Model; Policy maker; Snake envenomation; Snakebite

Indexed keywords

CREATININE; SNAKE VENOM; SNAKE VENOM ANTISERUM;

CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG UTILIZATION; ENVENOMATION; HEALTH CARE POLICY; HUMAN; KIDNEY FAILURE; MEDICAL EDUCATION; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 45149134591     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/07-WEME-CON-1591.1     Document Type: Article

References (47)

1. Stock RP, Massougbodji A, Alagon A, Chippaux JP. Bringing antivenoms to sub-Saharan Africa. Nature. 2007;25:173-177.
2. Wilde H, Thipkong P, Sitprija, Chaiyabutr N. Hetrologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Med. 1996;125:233-236.
3. Chippaux JP, Goyffon M. Round table and synthesis of the meeting. Bull Soc Pathol Exot. 2002;95:217-219.
4. Gutierrez JM, Theakston RDG, Warrell DA. Confronting the neglected problem of snakebite envenoming: the need for a global partnership. PLoS Med. 2006;3:e150.
5. World Health Organization. Rabies and envenomings: a neglected health public health issue. Report of a consultative meeting. Geneva, Switzerland: World Health Organization; 2007.
6. Warrell DA. WHO/SEARO guidelines for the clinical management of snakebite in the Southeast Asian region. SE Asian J Trop Med Pub Health. 1999;30:1-85.
7. Chippaux JP. Snakebites: appraisal of the global situation. Bull World Health Org. 1998;76:515-524.
8. World Health Organization. Animal sera. Available at: http://www.who.int/bloodproducts/animal_sera/en/. Accessed October 17, 2007.
9. Simpson ID. Snakebite management in India, the first few hours: a guide for primary care physicians. J Indian Med Assoc. 2007;105:324-335.
10. Auerbach PS, Norris RL. Disorders caused by reptile bites and marine animal exposures. In: Kaspar DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:2593-2600.
11. Rawlins M, Vale JA. Drug therapy and poisoning. In: Kumar P, Clark M, eds. Clinical Medicine. 6th ed. Philadelphia, PA: Elsevier Ltd; 2005:991-1024.
12. Modi NS. Modi's Textbook of Medical Jurisprudence and Toxicology. Bombay, India: N.M. Tripathi Private Limited; 1988.
13. Quadir G, Memon S. Snake bite. In: Iliyas M, ed. Public Health and Community Medicine. 7th ed. Karachi, Pakistan: Time Publisher; 2006:475-485.
14. Simpson ID, Norris RL. Snake antivenom product guidelines in India: the devil is in the details. Wilderness Environ Med. 2007;18:163-168.
15. Warrell DA. Bites by venomous snakes outside the Americas. In: Auerbach PS, ed. Wilderness Medicine. 5th ed. St. Louis, MO: Mosby; 2007:1086-1123.
16. Suleman M, Shahab S, Rab M. Snake bite in the Thar desert. J Pak Med Assoc. 1998;48:306-308.
17. Mal R. A study of snake bite cases. J Pak Med Assoc. 1994;44:289.
18. Ansari AK, Sheikh SA. Management of vipridae snake bite. Pak Armed Forces Med J. 2000;50:26-28.
19. Seir F. Snake bite cases in CMH Bahawalpur. Pak Armed Forces Med J. 2001;51:173-176.
20. Khan B, Naseem A. Guidelines for management of snake bite cases. Pak Armed Forces Med J. 2000;50:51-55.
21. Dutta T, Mukta V. Snakebite. J Indian Med Assoc. 2006;104:252-254.
22. Ertem K, Esenkaya I, Kaygusuz MA, Turan C. Our clinical experience in the treatment of snakebites. Acta Orthop Traumatol Turc. 2005;39:54-58.
23. Forks TP. Evaluation and treatment of poisonous snakebites. Am Fam Physician. 1994;50:123-130.
24. Virmani SK. Envenomation syndromes and their management. In: Anand AC, ed. Textbook of Environmental Emergencies. 1st ed. Pune, India: Armed Forces Medical College; 2006: 97-101.
25. Kiran S, Senthilnatahn TA. Management of snake envenomation. Updates Anaesthesia. 2003;16:13-18.
26. Pillay VV. Irritants of animal origin. In: Pillay VV, ed. Modern Medical Toxicology. 3rd ed. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd; 2005:120-142.
27. Muguti GI, Maramba A, Washaya CT. Snake bites in Zimbabwe: a clinical study with emphasis on the need for antivenom. Cent Afr J Med. 1994;40:83-88.
28. Sii Polyvalent Anti-Snake Venom Serum (Lyophilised) Central Africa [package insert]. Pune, India: Serum Institute of India Ltd.
29. McNamee D. Tackling venomous snakebites worldwide. Lancet. 2001;357:1680-1681.
30. Kulkarni ML, Anees S. Snake venom poisoning: experience with 633 cases. Indian Pediatrics. 1998;(31):1239-1243.
31. Hon KLE, Chow CM, Cheung KL, Leung TF. Snakebite in a child: could we avoid the anaphylaxis or the fasciotomies. Ann Acad Med Singapore. 2005;34:454-456.
32. Chippaux JP. Snake Venoms and Envenomations. Florida: Krieger Publishing Company; 2006:211-246.
33. Bambery P, Malhotra HS, Chugh KS. Clinical problems of snakebites in India. In: Tu A, ed. Toxin Related Diseases. New Delhi, India: IBH; 1993:419-443.
34. Warrell DA. Injuries, envenoming, poisoning, and allergic reactions caused by animals. In: Warrell DA, Cox TM, Firth JD, ed. Oxford Textbook of Medicine. 4th ed. Oxford, England: Oxford University Press; 2005:923-947.
35. Warrell DA. Venomous bites and stings in the tropical world. Med J Aust. 1993;159:773-779.
36. Adhikari DD, Singh PR, Kirubairaj M, Arsdell RV, David SS. Snake envenomation. In: David SS, ed. Handbook of Emergency Medicine. 6th ed. Vellore, India: Christian Medical College Vellore; 2006:74-75.
37. Sharma SK, Khanal B, Pokhrel P, Khan A, Koirala S. Snakebite - reappraisal of the situation in eastern Nepal. Toxicon. 2003;41:285-289.
38. Harish R, Digra SK. Snake bite neurotoxicity: reversal after 84 hours. Indian Pediatrics. 2007;44:233.
39. Sharma SK, Koirala S, Dahal G. Krait bite requiring high dose antivenom: a case report. Southeast Asian J Trop Med Public Health. 2002;33:170-171.
40. Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347-356.
41. Srimannarayana J, Dutta TK, Sahai A, Badrinath S. Rational use of anti-snake venom (asv): trial of various regimens in haemotoxic envenomation. J Assoc Phys India. 2004;52:788-793.
42. Junghanss T, Bodio M. Medically important venomous animals: biology, prevention, first aid and clinical management. Travel Medicine. 2006;46:1309-1317.
43. Stone R, Seymour J, Marshall O. Plastic containers and the whole blood clotting test: glass remains the best option. Trans Roy Soc Trop Med Hyg. 2006;100:1168-1172.
44. Visser LE, Kyei-Faried S, Belcher DW. Protocols and monitoring to improve snakebite in rural Ghana. Trans R Soc Trop Med Hyg. 2004;98:278-283.
45. Cheng AC, Winkel KD. Snakebite and antivenoms in Asia-Pacific: wokabaut wantaim raka hebou ("walking together"). Med J Aust. 2001;175:648-651.
46. Benitez JA, Rifakis PM, Vargas JA, Cabaniel GC. Trends in fatal snakebites in Venezuela 1995-2002. Wilderness Environ Med. 2007;18:209-213.
47. De Silva HJ, Fonseka MMD, Gunatilake SB, Kularatne SAM, Sellahewa KH. Anti-venom for snakebite in Sri Lanka. CMJ. 2002;(2):43-45.